Picard Medical Reports Revenue Growth for Q1 2026
Picard Medical, Inc. announced a 79.9% increase in revenue for the first quarter of 2026, reaching $1.1 million, driven by higher utilization of its Total Artificial Heart and adjusted pricing for driver rentals. Effective reimbursement conditions in the U.S. contributed to the growth. The company plans to file full financial results by May 15, 2026.
– Growth driven by increased U.S. demand and pricing –
– Growth driven by increased U.S. demand and pricing –